Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1995
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/06/1995EP0684949A1 Chemical compounds
12/05/1995US5472977 Administering 3,4-(diphenyl)chromans
12/05/1995US5472962 Antiestrogenic agents
12/05/1995US5472694 Method for manufacturing tea by treating the leaves of Cyclobalanopsis stenophylla
11/1995
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/29/1995EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
11/29/1995EP0540560B1 Ancrod-like proteins, their preparation and their use
11/29/1995CN1112560A Piperidine derivatives and anti-platelet agents containing the same
11/29/1995CN1112416A Cosmetic or pharmaceutical compositions consisting of liposomes
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470867 Imidazoles and their salts having antagonistic activity to angiotesin II recetors
11/28/1995US5470854 Antiestrogens
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470588 Hydrogen iodide
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/22/1995EP0683159A1 Substituted furoxanes
11/22/1995CN1112364A Piperazine derivatives and salts thereof
11/22/1995CN1112112A New bicyclic derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
11/22/1995CN1112019A Novel process for the preparation of cetrorelix lyophilisate
11/22/1995CN1111988A Use of aromatic steroids substituted in position 3 by a disubstituted aminoalkyloxy chain in order to obtain a medicament intended to control fertility and in particular male fertility, and the pharma
11/21/1995US5468879 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/21/1995US5468757 For treating stroke or myocardial infarction in humans
11/21/1995CA2149854A1 Substituted furoxanes
11/21/1995CA1337591C Therapeutic composition comprising oestrogen and antioestrogen
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/15/1995EP0682017A1 Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents
11/15/1995EP0682015A1 Piperidine derivates and anti-platelet agents containing the same
11/15/1995EP0681835A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
11/15/1995EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof
11/15/1995CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/1995CN1111507A Controlled release oxybutynin formulations
11/14/1995US5466712 Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
11/14/1995US5466701 Saccharin derivative proteolytic enzyme inhibitors
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/12/1995CA2149091A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995WO1995029675A1 Method and composition for treating renal disease and failure
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2189070A1 Method and composition for treating renal disease and failure
11/08/1995EP0680758A1 Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
11/08/1995EP0680472A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/07/1995US5464872 Sleep disorders
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/06/1995CA2148666A1 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
11/06/1995CA2148302A1 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
11/02/1995WO1995029152A1 Benzamide derivatives as vasopressin antagonists
11/02/1995WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/02/1995WO1995028932A1 Transdermal delivery of alpha adrenoceptor blocking agents
11/02/1995WO1995028921A1 Ecadotril as a renal protective agent
11/02/1995EP0679091A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
11/02/1995EP0679084A1 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
10/1995
10/31/1995US5462962 Tetrahydrobenz[c,d]indole serotonin agonists
10/31/1995US5462950 Administering raloxifene or salt
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028397A1 Alpha1c adrenergic receptor antagonists
10/26/1995WO1995028388A1 Quinolone derivative for treatment of urinary incontinence
10/26/1995WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187767A1 Alpha1c adrenergic receptor antagonists
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678101A1 Growth differentiation factor-9
10/24/1995US5461065 Methods for inhibiting endometriosis
10/24/1995US5461064 Methods of inhibiting atrophy of the skin and vagina
10/24/1995CA1337420C (substituted aralkyl) heterocyclic compounds
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027503A1 Antirestenosis protein
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677042A1 Selective ligands of receptors 5-ht 1d?-5ht 1b? derived from indole-piperazine useful as medicaments
10/18/1995EP0676959A1 Endothelin receptor antagonists
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0676202A2 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility
10/11/1995EP0675902A1 Endothelin antagonists
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 562